Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Loc'h

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Bioconjugate Chemistry|September 20, 2000
General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studiesB Kühnast, F Dollé, S Terrazzino, et al.
Revue Neurologique|January 1, 1993
[Positron-emission tomographic study of the dopaminergic system in a case of secondary unilateral tremor after mesencephalic hematoma]A De Recondo, P Rondot, C Loc'h, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1991
The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisurideJ L Martinot, M L Paillère-Martinot, C Loc'h, et al.
Psychopharmacology|January 1, 1989
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsJ C Baron, J L Martinot, H Cambon, et al.
The American Journal of Psychiatry|January 1, 1990
Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patientsJ L Martinot, P Peron-Magnan, J D Huret, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1994
Central D2 receptors and negative symptoms of schizophreniaJ L Martinot, M L Paillère-Martinot, C Loc'h, et al.
Life Sciences|January 6, 2000
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experimentsJ Helfenbein, C Loc'h, M Bottlaender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2016
Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [<sup>18</sup>F]PBR102 and [<sup>18</sup>F]PBR111S Eberl, A Katsifis, M A Peyronneau, et al.
Nuclear Medicine and Biology|September 3, 1999
Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptorsO Langer, C Halldin, F Dollé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2014
Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [(18)F]PBR102 and [ (18)F]PBR111 in a model of excitotoxin-induced neuroinflammationP D Callaghan, C A Wimberley, G L Rahardjo, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Bioconjugate Chemistry|September 20, 2000
General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studiesB Kühnast, F Dollé, S Terrazzino, et al.
Revue Neurologique|January 1, 1993
[Positron-emission tomographic study of the dopaminergic system in a case of secondary unilateral tremor after mesencephalic hematoma]A De Recondo, P Rondot, C Loc'h, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1991
The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisurideJ L Martinot, M L Paillère-Martinot, C Loc'h, et al.
Psychopharmacology|January 1, 1989
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsJ C Baron, J L Martinot, H Cambon, et al.
The American Journal of Psychiatry|January 1, 1990
Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patientsJ L Martinot, P Peron-Magnan, J D Huret, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1994
Central D2 receptors and negative symptoms of schizophreniaJ L Martinot, M L Paillère-Martinot, C Loc'h, et al.
Life Sciences|January 6, 2000
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experimentsJ Helfenbein, C Loc'h, M Bottlaender, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 5, 2016
Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [<sup>18</sup>F]PBR102 and [<sup>18</sup>F]PBR111S Eberl, A Katsifis, M A Peyronneau, et al.
Nuclear Medicine and Biology|September 3, 1999
Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptorsO Langer, C Halldin, F Dollé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2014
Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [(18)F]PBR102 and [ (18)F]PBR111 in a model of excitotoxin-induced neuroinflammationP D Callaghan, C A Wimberley, G L Rahardjo, et al.
Pageof 6